Plain-English translation of NCT06841328 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing stem cell injections—specifically cells derived from fat tissue or their byproducts—to help restore fertility in people whose ovaries or testes have failed. The treatment is designed to repair damaged tissue and restart natural hormone and sperm or egg production. This approach offers hope for people who haven't responded well to standard hormone treatments or surgery.
Standard treatments like hormone therapy help ease symptoms but don't restore the ability to have children naturally. Surgery to retrieve sperm or eggs carries risks and isn't always successful. This trial exists to explore whether the new treatment might offer a safer, less invasive way to help reproductive organs work again.
You likely qualify if…
You likely don't qualify if…
You would visit the clinic for a stem cell or exosome injection directly into your ovaries or testes, a procedure done with ultrasound guidance. The trial will track your safety and measure whether your fertility improves, hormone levels normalize, and sperm or egg production restarts. You'll need to follow the study protocol and attend follow-up visits so the research team can monitor your response to the treatment over time.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
United Arab Emirates